These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11707010)

  • 1. Four cases of tendinopathy in patients on statin therapy.
    Chazerain P; Hayem G; Hamza S; Best C; Ziza JM
    Joint Bone Spine; 2001 Oct; 68(5):430-3. PubMed ID: 11707010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Polymyositis induced or associated with lipid-lowering drugs: five cases].
    Fauchais AL; Iba Ba J; Maurage P; Kyndt X; Bataille D; Hachulla E; Parent D; Queyrel V; Lambert M; Michon Pasturel U; Hatron PY; Vanhille P; Devulder B
    Rev Med Interne; 2004 Apr; 25(4):294-8. PubMed ID: 15050796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin-induced calcific Achilles tendinopathy in rats: comparison of biomechanical and histopathological effects of simvastatin, atorvastatin and rosuvastatin.
    Kaleağasıoğlu F; Olcay E; Olgaç V
    Knee Surg Sports Traumatol Arthrosc; 2017 Jun; 25(6):1884-1891. PubMed ID: 26275370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
    J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins and tendinopathy: a systematic review.
    Teichtahl AJ; Brady SR; Urquhart DM; Wluka AE; Wang Y; Shaw JE; Cicuttini FM
    Med J Aust; 2016 Feb; 204(3):115-21.e1. PubMed ID: 26866552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mini-Review: Toxic Tendinopathy.
    Bolon B
    Toxicol Pathol; 2017 Oct; 45(7):834-837. PubMed ID: 28553748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term safety of statin-fibrate combination treatment in the management of hypercholesterolaemia in patients with coronary artery disease.
    Feher MD; Foxton J; Banks D; Lant AF; Wray R
    Br Heart J; 1995 Jul; 74(1):14-7. PubMed ID: 7662446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolving role of statins in the management of atherosclerosis.
    Vaughan CJ; Gotto AM; Basson CT
    J Am Coll Cardiol; 2000 Jan; 35(1):1-10. PubMed ID: 10636252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tendinous disorders attributed to statins: a study on ninety-six spontaneous reports in the period 1990-2005 and review of the literature.
    Marie I; Delafenêtre H; Massy N; Thuillez C; Noblet C;
    Arthritis Rheum; 2008 Mar; 59(3):367-72. PubMed ID: 18311771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggressive lipid therapy in the statin era.
    Farmer JA
    Prog Cardiovasc Dis; 1998; 41(2):71-94. PubMed ID: 9790411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapies.
    Glueck CJ; Aregawi D; Agloria M; Khalil Q; Winiarska M; Munjal J; Gogineni S; Wang P
    Clin Ther; 2006 Jun; 28(6):933-42. PubMed ID: 16860175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rhabdomyolysis in patients with preexisting myopathy, treated with antilipemic agents].
    Franc S; Bruckert E; Giral P; Turpin G
    Presse Med; 1997 Dec; 26(38):1855-8. PubMed ID: 9569908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of HMG-CoA reductase inhibitors on skeletal muscle: are all statins the same?
    Evans M; Rees A
    Drug Saf; 2002; 25(9):649-63. PubMed ID: 12137559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New clinical perspectives of hypolipidemic drug therapy in severe hypercholesterolemia.
    Stefanutti C; Morozzi C; Di Giacomo S
    Curr Med Chem; 2012; 19(28):4861-8. PubMed ID: 22963620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Hypercholesterolemia, Appropriateness of Therapeutic Approaches and New Drugs in Patients with High Cardiovascular Risk.
    Agabiti Rosei E; Salvetti M
    High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):217-30. PubMed ID: 27567901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of lipid-lowering therapy and cholesterol goal attainment in Finland: the National FINRISK Study.
    Alemao E; Yin D; Sintonen H; Salomaa V; Jousilahti P
    Am J Cardiovasc Drugs; 2006; 6(5):349-55. PubMed ID: 17083270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current perspectives on statins.
    Maron DJ; Fazio S; Linton MF
    Circulation; 2000 Jan; 101(2):207-13. PubMed ID: 10637210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter comparison of micronized fenofibrate and simvastatin in patients with primary type IIA or IIB hyperlipoproteinemia.
    Steinmetz A; Schwartz T; Hehnke U; Kaffarnik H
    J Cardiovasc Pharmacol; 1996 Apr; 27(4):563-70. PubMed ID: 8847874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin use and risk of pancreatic cancer: results from a large, clinic-based case-control study.
    Walker EJ; Ko AH; Holly EA; Bracci PM
    Cancer; 2015 Apr; 121(8):1287-94. PubMed ID: 25649483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.